¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Ascorbic Acid Coated 96% Type SC"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • malonic acid
    ¸»·Ð»ê
  • myristic acid
    ¹Ì¸®½ºÆ¾»ê
  • mandelic acid
    ¸¸µ¨»ê
  • methacrylic acid
    ¸ÞŸũ¸±»ê
  • methylhippuric acid
    ¸ÞÆ¿È÷Ǫ¸£»ê
  • N-acetylneuraminic acid
    N-¾Æ¼¼Æ¿´º¶ó¹Î»ê
  • neuraminic acid
    ´º¶ó¹Î»ê
  • neurostearic acid
    ½Å°æÁö¹æ»ê
  • nicotinic acid
    ´ÏÄÚÆ¾»ê
  • nitric acid
    Áú»ê
  • nitrobenzoic acid
    ´ÏÆ®·Îº¥Á¨»ê
  • nitrohydrochloric acid
    Áú¿°»ê, ¿Õ¼ö
  • nitrous acid
    ¾ÆÁú»ê
  • normal fatty acid
    Ç¥ÁØÁö¹æ»ê
  • nucleic acid
    ÇÙ»ê
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • nitrobenzoic acid
    ³ªÀÌÆ®·Îº¥Á¨»ê
  • nitrohydrochloric acid
    Áú¿°»ê, ¿Õ¼ö
  • nitrous acid
    Áú»ê
  • normal fatty acid
    Ç¥ÁØÁö¹æ»ê
  • nucleic acid
    ÇÙ»ê
  • oleic acid
    ¿Ã·¹»ê
  • organic acid
    À¯±â»ê
  • oxalic acid
    ¿Á»ì»ê
  • oxaloacetic acid
    ¿Á»ì¾Æ¼¼Æ®»ê
  • pantoic acid
    ÆÇÅäÀλê
  • pantothenic acid
    ÆÇÅäÅÙ»ê
  • phenolic acid
    Æä³î»ê
  • phenolsulfuric acid
    Æä³îȲ»ê
  • phenylpyruvic acid
    Æä´ÒÇÇ·çºê»ê
  • phosphopyruvic acid
    Æ÷½ºÆ÷ÇÇ·çºê»ê
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • aliphatic acid
    Áö¹æÁ·»ê(ò·Û¸ðéß«).
  • aliphatic amino acid
    Áö¹æÁ·¾Æ¹Ì³ë»ê
  • aloetic acid
    ¾Ë·Î¿¡Æ¾»ê.
  • alpha-amino acid nitrogen
    ¾ËÆÄ-¾Æ¹Ì³ë»êÁú¼Ò
  • alpha1-acid glycoprotein
    ¾ËÆÄ-»ê´ç´Ü¹é
  • amino acid
    ¾Æ¹Ì³ë»ê
  • amino acid analyzer
    ¾Æ¹Ì³ë»êºÐ¼®±â
  • amino acid determination
    ¾Æ¹Ì³ë»ê°áÁ¤(̽ïÒ)
  • amino acid pattern
    ¾Æ¹Ì³ë»êÇüÅÂ
  • amino acid sequence
    ¾Æ¹Ì³ë»ê ¼­¿­.
  • aminoacetic acid<³ª> acidum aminoaceticum
    ¾Æ¹Ì³ë¾Æ¼¼Æ®»ê.
  • aminohippuric acid
    ¾Æ¹Ì³ë ¸¶´¢»ê
  • anaphylaxis,arachidonic acid metabolitesin
    ¾Æ¶ó۵·»ê ´ë»ç¹°Áú(¡­ß« ÓÛÞóÚªòõ)
  • anthranilic acid
    ¾ÈÆ®¶ó´Ò»ê.
  • apoascorbic acid
    ¾ÆÆ÷¾Æ½ºÄÚ¸£ºó»ê.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • spinal type
    ô¼öÇü(ô±âÐúþ).
  • split electrode type probe
    ºÐÇÒ Àü±Ø ŽÃËÀÚ
  • split-electrode-type probe
    ºÐÇÒ Àü±Ø ŽÃËÀÚ (ÝÂùÜ ï³Ð¿ ÷®õºí­)
  • sthenic type
    ±Ù·ÂÇü(ÐÉæ³úþ).
  • storage-type
    ÃàÀûÇü
  • supporting cell [type ii glomus cell]
    ¹öÆÀ¼¼Æ÷
  • swaged cast type crown
    ¾ÐÀÎÇü±Ý°ü(äâìÔû¡ ÐÝή).
  • sympathicotonic type
    ±³°¨½Å°æ±äÀåÇü(¡­ÑÌíåúþ).
  • sympathicotonic type
    ±³°¨½Å°æ±äÀåÇü(¡­ÑÌíåúþ)
  • thinking type
    »ç°íÇü(ÞÖÍÅúþ).
  • triaxone type
    »ïÃàÇü(ß²õîúþ).
  • tuberculoid (type) leprosy
    À¯°áÇÙ³ª(׾̿ú·ÑÛ), °áÇپ糪(Ì¿ú·åÆÑÛ).
  • tuberculoid (type) leprosy
    À¯°áÇÙ³ª(׾̿ú·ÑÛ), °áÇپ糪(Ì¿ú·åÆ )
  • type A behavior
    AÇü Çൿ(ú¼ÔÑ).
  • type A encephalitis
    ±â¸é¼º ³ú¿°(ÐîØùàõÒàæú).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • folic acid reductase
    Æú»ê(ß«) ¸®´ÚÅ×À̽º
  • folinic acid
    Æú¸°»ê(ß«)
  • N5-formyltetrahydrofolic acid
    N5-Æ÷¸£¸» »ç¼ö¼Ò(ÞÌâ©áÈ)Æú»ê(ß«)
  • fulvic acid
    Ç®ºê»ê(ß«)
  • fumaric acid
    Ç»¸¶¸£»ê(ß«)
  • gamma aminobutyric acid
    °·¸¶ ¾Æ¹Ì³ëºêƼ¸£»ê(ß«)
  • general acid-base catalysis
    ÀϹÝ(ìéÚõ) »ê-¿°±â Ã˸Å(ß«-ç¤ÐñõºØÚ)ÀÛ¿ë
  • gibberellic acid
    Áö¹ö·¼¸°»ê(ß«)
  • glucoplastic amino acid
    ±Û·çÄÚ½º»ý¼º(ßæà÷) ¾Æ¹Ì³ë»ê(ß«)
  • glucuronic acid
    ±Û·çÅ¥·Ð»ê(ß«)
  • glucuronic acid oxidation pathway
    ±Û·çÅ¥·Ð»ê(ß«) »êÈ­°æ·Î(ß«ûùÌèÖØ)
  • glutamic acid
    ±Û·çŽ»ê(ß«)
  • glutaric acid
    ±Û·çŸ¸£»ê(ß«)
  • glycaric acid
    ±Û¶óÀÌÄ«¸£»ê(ß«)
  • glycerophosphoric acid
    ±Û¸®¼¼·ÎÀλê(×òß«)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 12
FAP familial adenomatous polyposis; familial amyloid polyneuropathy; fatty acid polyunsaturated; fatty a...
FPN ferric chloride, perchloric acid, and nitric acid [solution]
HA H antigen; Hakim-Adams [syndrome]; halothane anesthesia; Hartley [guinea pig]; headache; health alli...
HPAA hydroperoxyarachidonic acid; hydroxyphenylacetic acid; hypothalamo-pituitary-adrenal axis
IA ibotenic acid; immune adherence; immunoadsorbent; immunobiologic activity; impedance angle; indolami...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 12
AT(2) Angiotensin type 2
Anti-HIV-1 Anti-human immunodeficiency virus type 1
HIV-1 Anti-human immunodeficiency virus type 1
APS I Autoimmune polyendocrine syndrome type I
APS-1 Autoimmune polyglandular syndrome type 1
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • fumaric acid
    Ǫ¸¶¸£ »ê
    ºÒÆ÷È­ ÀÌ¿°±â»ê. Æ®¶óÀÌ Ä«¸£º¹½Ç»ê ȸ·ÎÀÇ Áß°£Ã¼.
  • humic acid
    È޹λê
  • humus acid
    ºÎ½Ä »ê
  • hydrofluoric acid
    ºÒÈ­ ¼ö¼Ò»ê
    ÁÖÁ¶¹° ¼¼Ã´ ¿ë¾×À¸·Î »ç¿ëµÇ´Â »ê ¿ë¾×.
  • isoniazid : 1. 4-pyridinecarboxylic acid hydrazide. ¹«»ö ¶Ç´Â ¹é»öÀÇ °áÁ¤À̳ª ºÐ¸». °áÇÙ Ä¡·á¿¡ »ç¿ëµÇ¸ç, ³»º¹ ¶Ç´Â ±ÙÀ°¿¡ ÁÖ»çÇÑ´Ù. 2. °áÇÙ±Õ¿¡ ´ëÇÑ È­ÇÐ ¿ä¹ý ¾àÀÇ Çϳª·Î 1Â÷ Ç×°áÇÙÁ¦·Î ¾²ÀδÙ. Àå±â Åõ¿©°¡ µÇ¹Ç·Î ºÎÀÛ¿ë Æ¯È÷ ½Å°æ, ¼ÒÈ­±â Àå¾Ö¿¡ ÁÖÀǸ¦ ¿ä
    µ¿Á¾ µ¶ ¿ä¹ý
    ÁúȯÀÇ »ý»ê¹° ¶Ç´Â ÀÌȯ Àå±â·ÎºÎÅÍ ÃßÃâÇÏ¿© ¸¸µç ¹°Áú·Î ÁúȯÀ» Ä¡·áÇÏ´Â ¹æ¹ý.
  • J acid

    Á¦ÀÌ »ê
    ¿°·áÀÇ Áß°£Ã¼.
  • jalapinolic acid
    ¾â¶óÇdzî»ê
    ÀÌÆ÷¹Ì¾Æ¿¡¼­ ¾ò¾îÁö´Â ¹è´çüÀÇ ¼ººÐ.
  • ketonic acid
    ÄÉÅæ »ê
  • kinotannic acid
    Ű³ëź´Ñ»ê
  • laccainic acid
    ¶óÄ«ÀÎ »ê
    Àû°¥»öÀÇ °áÁ¤ »ê.
  • laccic acid
    ¶óÅ© »ê
    ¶óÅ© ¿°·á¿¡¼­ ¾ò´Â Àû°¥»öÀÇ °áÁ¤¹°.
  • lactic acid
    À¯»ê
    Ä«¸£º¹½Ã±â, ¼ö»ê±â, ¸ÞÆ¿±â, ¼ö¼ÒÀÇ ³× ¿øÀÚ´ÜÀÌ °áÇÕÇÑ ºñ´ëĪ ź¼Ò ¿øÀÚ¸¦ °¡Áö´Â À¯±âÈ­ÇÕ¹°. È÷µå·Ï½Ã ÇÁ·ÎÇǿ»ê, ¶ôÆ®»ê, À¯»êÀ̶ó°íµµ ÇÑ´Ù. 1780³â K.W. ¼Ð·¹¿¡ ÀÇÇØ »êÆÐÇÑ ¿ìÀ¯ ¼Ó¿¡¼­ ¹ß°ßµÇ¾úÀ¸¸ç µ¿½Ä¹°°è¿¡ ³Î¸® Á¸ÀçÇÑ´Ù. D, L, DLÇüÀÇ ±¤ÇÐ À̼ºÁúü°¡ ÀÖ´Ù. L-Á¥»êÀº ÇØ´ç °úÁ¤ÀÇ ÃÖÁ¾ »ê¹°·Î¼­ ÇÇ·çºê»êÀÇ È¯¿ø¿¡ ÀÇÇØ »ý¼ºµÈ´Ù. Á¶ÇؼºÀÌ °­ÇÑ ÁÖ»ó °áÁ¤À̸ç, ³ì´ÂÁ¡Àº 25¡­26 ¡ÉÀÌ´Ù. ±ÙÀ°, µ¿¹°Á¶Á÷ ¼Ó¿¡ Á¸ÀçÇÏ¸ç »ç¶÷ÀÇ Ç÷¾× ¼Ó¿¡´Â 100 m§¤´ç 5¡­20 mgÀÌ Á¸ÀçÇϸç, ½ÉÇÑ ¿îµ¿¿¡ ÀÇÇØ Áõ°¡ÇÑ´Ù. ¿îµ¿¿¡ ÀÇÇÑ ±ÙÀ°ÀÇ ÇǷδ ±Û¸®ÄÚ°ÕÀÇ ºÐÇØ¿¡ ÀÇÇÑ L-Á¥»êÀÇ ÃàÀû°ú °ü°è°¡ ÀÖ´Ù. ÈÞ½Ä ½Ã¿¡´Â ±× ÀϺΰ¡ »êÈ­ ºÐÇØµÇÁö¸¸ ´ëºÎºÐ ¿ø·¡ÀÇ ±Û¸®ÄÚ°ÕÀ¸·Î ÀçÇÕ¼ºµÈ´Ù. D-Á¥»êÀº µÎ²¨¿î ÆÇ»ó °áÁ¤À̸ç, ³ì´ÂÁ¡Àº 26¡­27 ¡ÉÀÌ´Ù. DL-Á¥»ê
  • lactic acid bacteria
    Á¥»ê ±Õ
    ±Û·çÄÚ¿À½º µî ´ç·ù¸¦ ºÐÇØÇÏ¿© Á¥»êÀ» »ý¼ºÇÏ´Â ¼¼±Õ. ¶ôÆ®»ê±Õ, À¯»ê ±ÕÀ̶ó°íµµ ÇÑ´Ù. Á¥»ê ¹ßÈ¿¿¡ ÀÇÇØ »ý¼ºµÇ´Â Á¥»ê¿¡ ÀÇÇØ¼­ º´¿ø ±Õ°ú À¯ÇØ ¼¼±ÕÀÇ »ýÀ°ÀÌ ÀúÁöµÇ´Â ¼ºÁúÀ» À¯Á¦Ç°
  • lactic acid bacterium
    ¶ôÆ® ±Õ
  • lactic acid formation
    À¯»ê Çü¼º
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
type i error The statistical error (said to be of the first kind or alpha error) made in testing an hypothesis when it is concluded that a treatment or intervention is effective when it really is not. Sometimes referred to as a false positive.
(12 Dec 1998)
type I familial hyperlipoproteinaemia Hyperlipoproteinaemia characterised by the presence of large amounts of chylomicrons and triglycerides in the plasma when the patient has a normal diet, and their disappearance on a fat-free diet; low alpha-and beta-lipoproteins on a normal diet, with increase on fat-free diet; decreased plasma postheparin lipolytic activity; and low tissue lipoprotein lipase activity. It is accompanied by bouts of abdominal pain, hepatosplenomegaly, pancreatitis, and eruptive xanthomas; autosomal recessive inheritance.
See: familial lipoprotein lipase inhibitor.
Synonym: Burger-Grutz syndrome, familial fat-induced hyperlipaemia, familial hyperchylomicronaemia, familial hypertriglyceridemia, idiopathic hyperlipaemia.
(05 Mar 2000)
type IH mucopolysaccharidosis <syndrome> Mucopolysaccharidosis in which there is a deficiency of alpha-l-iduronidase, an accumulation of an abnormal intracellular material, and excretion of dermatan sulfate and heparan sulfate in the urine; with severe abnormality in development of skeletal cartilage and bone, with dwarfism, kyphosis, deformed limbs, limitation of joint motion, spadelike hand, corneal clouding, hepatosplenomegaly, mental retardation, and gargoyle-like facies; autosomal recessive inheritance.
See: mucolipidosis.
Synonym: dysostosis multiplex, Hurler's disease, lipochondrodystrophy, Pfaundler-Hurler syndrome, type IH mucopolysaccharidosis.
(05 Mar 2000)
type I H/S mucopolysaccharidosis <syndrome> Although clinically distinct diseases, fibroblasts from patients with Hurler syndrome and with Scheie syndrome do not cross complement in culture, suggesting that the enzyme defect is the same.
(18 Nov 1997)
type I hyperlipoproteinaemia <biochemistry> An rare inherited disorder where there is a deficiency of an enzyme (lipoprotein lipase) which breaks down fat molecules, causing the accumulation of fats or lipoproteins in the blood.
Symptoms in infancy include abdominal pain (appears as if its colic), failure to thrive and skin lesions (xanthomas).
Origin: Gr. Haima = blood
(27 Sep 1997)
type II acrocephalosyndactyly type II acrocephalosyndactyly
type II cells Cuboidal cell's connected with the squamous pulmonary alveolar cell's and having in their cytoplasm lamellated bodies (cytosomes) that represent the source of the surfactant that coats the alveoli.
Synonym: granular pneumonocytes, type II cells.
(05 Mar 2000)
type II collagen Collagen unique to cartilage, nucleus pulposis, notochord, and vitreous body; it forms as thin highly glycosylated fibrils.
(05 Mar 2000)
type II diabetes <disease> An often mild form of diabetes mellitus of gradual onset, usually in obese individuals over age 35; absolute plasma insulin levels are normal to high, but relatively low in relation to plasma glucose levels; ketoacidosis is rare, but hyperosmolar coma can occur; responds well to dietary regulation and/or oral hypoglycaemic agents, but diabetic complications and degenerative changes can develop.
(05 Mar 2000)
type II dip Late deceleration of the foetal heart rate, 30 seconds or more after the height of uterine contraction, as displayed on a foetal monitor graph.
(05 Mar 2000)
type II error The statistical error (said to be of the second kind or beta error) made in testing an hypothesis when it is concluded that a treatment or intervention is not effective when it really is. Sometimes referred to as a false negative.
(12 Dec 1998)
type II familial hyperlipoproteinaemia Hyperlipoproteinaemia characterised by increased plasma levels of beta-lipoproteins, cholesterol, and phospholipids, but normal triglycerides; heterozygotes have mild lipid changes and are susceptible to atherosclerosis in middle age, but homozygotes have severe changes often with generalised xanthomatosis and xanthelasma, and frank clinical atherosclerosis as young adults. The primary defect is a deficiency of apoprotein of VLDL, and the disorder is divided into two classes: 1) type IIA, which has elevated LDL due to a deficiency of the receptor or a modified apolipoprotein B-100; 2) type IIB, which has elevated LDL and triglycerides; autosomal dominant inheritance.
Synonym: familial hyperbetalipoproteinaemia, familial hypercholesteraemic xanthomatosis, familial hypercholesterolaemia.
(05 Mar 2000)
type II hyperlipoproteinaemia <biochemistry> A relatively rare (7 out of 1,000) genetic disease in which there is elevation in the blood triglycerides, cholesterol and low density lipoprotein (LDL). Also called type II hyperlipoproteinaemia, familial hyperlipoproteinaemia or familial hypercholesterolaemia.
Origin: Gr. Haima = blood
(27 Sep 1997)
type III acrocephalosyndactyly An autosomal dominant syndrome with variable expression of brachycephaly, maxillary hypoplasia, prominent ear crus, syndactyly, facial asymmetry, shallow orbits, telecanthus, and nasal septal deviation; may show mental retardation.
Synonym: Saethre-Chotzen syndrome.
(05 Mar 2000)
type III collagen Collagen characteristic of reticular fibres.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 12
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 12
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 12
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 12
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 12
ÅëÇÕ°Ë»ö ¿Ï·á